Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001363743.2(ASAH1):c.-89A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.906
PP5
Variant 8-18075559-T-C is Pathogenic according to our data. Variant chr8-18075559-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 93.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Review Status: criteria provided, single submitter
Collection Method: curation
This variant is interpreted as a Likely Pathogenic, for Farber lipogranulomatosis, Autosomal Recessive inheritance. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PS3 => Well-established functional studies show a deleterious effect (PMID:11241842). -
not provided Pathogenic:1
Oct 21, 2024
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
Published functional studies demonstrate a damaging effect with markedly reduced enzyme activity (PMID: 11241842); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as p.(Y52C); This variant is associated with the following publications: (PMID: 34088014, 11241842, 32875576) -
Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);.;.;Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);.;.;Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);Loss of phosphorylation at Y36 (P = 0.1059);.;.;.;